{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:12:12Z","timestamp":1785334332313,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,22]]},"DOI":"10.7759\/cureus.58740","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T14:43:34Z","timestamp":1713797014000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Series of Rheumatoid Arthritis Flare Including Extra-articular Manifestations Following SARS-CoV-2 mRNA Vaccination: A Comprehensive Cytokine Assay"],"prefix":"10.7759","author":[{"given":"Narumichi","family":"Iwamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katusmi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Takatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitaka","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref2","unstructured":"Coronavirus pandemic (COVID-19). (2023). Accessed. June 6, 2023: https:\/\/ourworldindata.org\/coronavirus."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102959","article-title":"Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)","volume":"134","author":"Ma M","year":"2023","unstructured":"Ma M, Santosa A, Fong W, et al.. Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING). J Autoimmun. 2023, 134:102959. 10.1016\/j.jaut.2022.102959","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00108-9","article-title":"Flare of rheumatoid arthritis after COVID-19 vaccination","volume":"3","author":"Terracina KA","year":"2021","unstructured":"Terracina KA, Tan FK. Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol. 2021, 3:e469-70. 10.1016\/S2665-9913(21)00108-9","journal-title":"Lancet Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11336","article-title":"Incidence of disease flare after BNT162b2 coronavirus disease 2019 vaccination in patients with rheumatoid arthritis in remission","volume":"3","author":"Bixio R","year":"2021","unstructured":"Bixio R, Bertelle D, Masia M, Pistillo F, Carletto A, Rossini M. Incidence of disease flare after BNT162b2 coronavirus disease 2019 vaccination in patients with rheumatoid arthritis in remission. ACR Open Rheumatol. 2021, 3:832-3. 10.1002\/acr2.11336","journal-title":"ACR Open Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.31138\/mjr.140223.sof","article-title":"Safety of COVID-19 vaccine in patients with rheumatic and musculoskeletal diseases","author":"Younis AA","year":"2024","unstructured":"Younis AA, Ridha AA. Safety of COVID-19 vaccine in patients with rheumatic and musculoskeletal diseases. Mediterr J Rheumatol. 2024,","journal-title":"Mediterr J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2023.2193286","article-title":"Hypocomplementemic urticarial vasculitis case with hemophagocytic lymphohistiocytosis following SARS-CoV-2 mRNA vaccination","volume":"46","author":"Iwamura N","year":"2023","unstructured":"Iwamura N, Eguchi K, Koga T, et al.. Hypocomplementemic urticarial vasculitis case with hemophagocytic lymphohistiocytosis following SARS-CoV-2 mRNA vaccination. Immunol Med. 2023, 46:97-107. 10.1080\/25785826.2023.2193286","journal-title":"Immunol Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02200-4","article-title":"Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis","volume":"22","author":"Koga T","year":"2020","unstructured":"Koga T, Sumiyoshi R, Furukawa K, et al.. Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis. Arthritis Res Ther. 2020, 22:108. 10.1186\/s13075-020-02200-4","journal-title":"Arthritis Res Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis Classification Criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha D","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, et al.. 2010 rheumatoid arthritis Classification Criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010, 62:2569-81. 10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"ref10","unstructured":"Japanese Ministry of Health, Labour and Welfare. Malignant rheumatoid arthritis. Accessed. January 2, 2024: http:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000062437.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102030-00004","article-title":"Drug-induced urticaria. Recognition and treatment","volume":"2","author":"Shipley D","year":"2001","unstructured":"Shipley D, Ormerod AD. Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol. 2001, 2:151-8. 10.2165\/00128071-200102030-00004","journal-title":"Am J Clin Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama S","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021, 80:384-91. 10.1136\/annrheumdis-2020-218946","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported Registry","volume":"79","author":"Gianfrancesco M","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, et al.. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported Registry. Ann Rheum Dis. 2020, 79:859-66. 10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"EULAR view-points on SARS-CoV-2 vaccination in patients with RMDs. (2022). Accessed. June 6, 2023: https:\/\/doi.org\/10.1136\/annrheumdis-2021-221965.","DOI":"10.1136\/annrheumdis-2021-221965"},{"key":"ref15","unstructured":"American College of Rheumatology Research and Education Foundation. COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases. (2023). Accessed. June 6, 2023: https:\/\/rheumatology.org\/covid-19-guidance."},{"key":"ref16","unstructured":"About novel coronavirus (COVID-19) and vaccine (information for physicians). (2023). Accessed. June 6, 2023: https:\/\/www.ryumachi-jp.com\/information\/medical\/covid-19\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano T","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021, 33:127-48. 10.1093\/intimm\/dxaa078","journal-title":"Int Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238475-a-case-series-of-rheumatoid-arthritis-flare-including-extra-articular-manifestations-following-sars-cov-2-mrna-vaccination-a-comprehensive-cytokine-assay","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T20:27:00Z","timestamp":1731788820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238475-a-case-series-of-rheumatoid-arthritis-flare-including-extra-articular-manifestations-following-sars-cov-2-mrna-vaccination-a-comprehensive-cytokine-assay"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.58740","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,22]]}}}